More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

Second letter from Crescent Capital

Aug 12, 2022 at 9:18 AM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Aug 12, 2022 at 9:18 AM EDT

On 6ix: 6ix.com/news/second-letter-from-crescent-capital

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

Story so far

  • Letter received from Crescent CapitalAug 12, 2022
  • Letter from Crescent Capital PartnersDec 21, 2021

Earlier from Australian Clinical Labs

  • Letter received from Crescent CapitalAug 12, 2022
  • Appendix 4E - Preliminary Financial ReportAug 9, 2022
  • FY22 Investor PresentationAug 9, 2022
  • Response to Market EnquiriesJun 5, 2022
  • S&P DJI Announces March 2022 Quarterly RebalanceMar 4, 2022

Later from Australian Clinical Labs

  • S&P DJI Announces September 2022 Quarterly RebalanceSep 2, 2022
  • 2022 AGM - addresses to shareholdersOct 18, 2022
  • 1H23 results investor presentationFeb 19, 2023
  • Appendix 4D and 1H23 financial reportsFeb 19, 2023
  • Takeover Offer for Healius LimitedMar 19, 2023
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer